ABSTRACT
Introduction
Stroke is the third leading cause of death and the leading cause of adult disability in North America, Europe and Asia. Intracranial cerebral atherosclerosis accounts for approximately 8-10% of all ischaemic strokes. Possible causes include hypoperfusion, thrombosis at the site of stenosis, thromboembolic events and direct occlusion of small penetrating vessels. (1) As carotid artery atherosclerosis is an important cause of ischaemic stroke, correcting the stenosis at the level of the carotid vessels is the treatment of choice. It can be surgical (carotid endarterectomy; CEA) or endovascular (carotid angioplasty with stenting; CAS). (1, 2) The latter has several benefits such as shorter hospitalisation, avoidance of open neck surgery as well as the ability to treat a technically difficult stenosis. Whether carotid stenting is superior to the classical surgical approach remains unclear. Studies have shown that the risk of the composite primary outcome of stroke, myocardial infarction or death, did not differ significantly, however there was a higher risk of stroke with the endovascular approach and a higher risk of myocardial infarction after endarterectomy. (1, 3) Late outcomes with CAS are comparable to those of CEA. (2) Complications of both procedures include cerebral embolism, arterial dissection, focal hyperperfusion as well as cerebral hyperperfusion syndrome (CHS) and intracranial haemorrhage (ICH). (1,3,4) CHS was primarily described as a combination of increased blood pressure together with clinical signs -ipsilateral migraine -like headache, seizure and transient focal neurological deficits in the absence of cerebral ischaemia after successful carotid endarterectomy. (5, 6 ) A similar phenomenon is described in the analogue endovascular procedure. (6, 7) Another complication of the procedure is also well known -ICH. This may be a consequence of CHS (6, 8) or a completely different entity as some authors propose. (9) Pathophysiology of cerebral hyperperfusion syndrome
The exact mechanism is still unknown but seems to be multifactorial in origin. (4, 6) However, there are two main mechanisms which contribute to the development of CHS -impaired cerebral autoregulation as well as postoperatively elevated systemic blood pressure. The main mechanism in normal cerebral autoregulation is cerebrovascular reactivity defined as the ability of the arterioles to constrict or to dilate in response to specific stimuli such as alteration of blood flow or change of partial pressure of carbon dioxide. The right internal cerebral artery (ACI) stenosis was symptomatic -the patient suffered right medium cerebral artery (ACM) territory stroke more than a year before the CAS. Risk factors included diabetes mellitus and high degree of stenosis. A Tight stenosis of the right ACI with very slow flow to right cerebral hemisphere is seen on digital subtraction angiography (DSA). B Magnification view shows near occlusion of the ACI caused by calcified plaque. C Stenosis was resolved with two self-expandable stents. D Significantly improved flow to the right cerebral hemisphere is seen at the end of the procedure when the patient was without clinical signs of hyperperfusion. F Less than an hour after the CAS (refractory hypertension as risk factor). E Dramatic neurological deterioration of the patient was caused by a massive ICH that resulted in a fatal outcome. Figure 1A . Figure 1B . Figure 1C .
Patients, who suffer from carotid stenosis, have maximally vasodilatated cerebral arterioles in order to maintain adequate blood supply to brain tissue. The severity of autoregulation impairment depends on several factors such Figure 1D . Figure 1E . Figure 1F .
as the duration and the intensity of cerebral hypoperfusion. The latter depends on the grade of ipsilateral carotid stenosis, the presence of contralateral carotid occlusion as well as the collateral flow. (6) The loss of ability to dilate in order to maintain adequate perfusion is the main problem in the pathogenesis of CHS. After revascularization, cerebral arterioles fail to constrict as a normal response to elevated blood pressure.
The latter reaches the capillary bed and causes cerebral oedema and/or haemorrhage. (3) The second mechanism, encountered in the pathogenesis of CHS, is postoperatively elevated systemic blood pressure. Hypertension is especially well known after CEA and it is due to receptor denervation. It leads to increased cerebral blood flow and consequently to hyperperfusion of previously hypoperfused brain tissue. This leads to cerebral oedema and elevated intracranial pressure as well as to increased levels of norepinephrine which additionally contribute to elevated blood pressure.
Other possible causes include elevated cranial levels of norepinephrine due to central nervous system sympathomimetic mechanism, perioperative stress and usage of specific anaesthetics during the procedure.
The incidence of CHS and ICH after CAS
Hyperperfusion occurs among 10-13% of patients. (4,6,10) However, the inci- Figure 2 . Patient with chronic left sided internal cerebral artery (ACI) occlusion and asymptomatic high grade right sided ACI stenosis treated with carotid angioplasty with stenting (CAS) in whom signs of hyperperfusion occurred 5 days after the procedure. Computer tomography angiography of the right ACI before (A) and after (B) the procedure. The patient was urgently readmitted to the hospital 5 days after the CAS due to a sudden early morning migraine -like headache localized frontally (non responsive to non steroid analgesics), nausea and vomiting. An hour after the first symptoms hemiparesis with bursts of epileptic seizures predominantly in the left arm occurred. The only risk factor was poorly controlled long standing hypertension. White matter oedema in confined region of the right fronto-parietal region was noticed on computer tomography (CT) (C) and magnetic resonance imaging (MRI) (D). E Hyperperfusion in the same confined region was confirmed with MR perfusion imaging, as shown on cerebral blood flow map. After admission to the intensive care unit for epileptic status, the patient underwent a full neurological recovery. F Follow-up CT one month later revealed complete reversibility of changes in brain tissue. Figure 2A . Figure 2B . Figure 2C . Figure 2D . Figure 2E . Figure 2F .
dence of clinical manifestations such as CHS and ICH is estimated on the basis of retrospective reviews and is still uncertain -the incidence of CHS and ICH after CAS was from 1. 1% and as high as 5% (3, 6, 11) Due to early discharge after the procedure patients and general practitioners should be aware of the complications.
Monitoring of blood pressure and treatment of hypertension is therefore strongly recommended for at least two weeks after the procedure.
Patients should return to hospital in case of severe headache and/or if systolic blood pressure exceeds 160 mmHg. (6, 11, 27, 28) 
Conclusions
The number of endovascular procedures in increasing and so are the complications.
The role of the interventional neuroradiologist as well as the rest of the team is to prevent, identify and to treat the complications as soon as possible. Therefore we recommend a multidisciplinary approach to patients, especially the ones with increased risk.
